annb0t
Top 20
Paradigm Biopharmaceuticals
Top-line phase 2 trial data shows disease modifying potential and pain reduction
MELBOURNE, Australia, April 11, 2023 (GLOBE NEWSWIRE) -- Australiaâs Paradigm Biopharmaceuticals Ltd (ASXAR) says analysis of six-month trial data shows injectable pentosan polysulfate sodium (iPPS) may slow the progression of osteoarthritis of the knee.
In October 2022, Paradigm said its phase 2 clinical study met its primary endpoint of a change from baseline to day 56 in one ...
>>> Read more: Australiaâs Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up
Top-line phase 2 trial data shows disease modifying potential and pain reduction
MELBOURNE, Australia, April 11, 2023 (GLOBE NEWSWIRE) -- Australiaâs Paradigm Biopharmaceuticals Ltd (ASXAR) says analysis of six-month trial data shows injectable pentosan polysulfate sodium (iPPS) may slow the progression of osteoarthritis of the knee.
In October 2022, Paradigm said its phase 2 clinical study met its primary endpoint of a change from baseline to day 56 in one ...
>>> Read more: Australiaâs Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up